LifeStance Health Group (NASDAQ:LFST) Sees Large Volume Increase – What’s Next?

LifeStance Health Group, Inc. (NASDAQ:LFST) saw unusually-strong trading volume on Tuesday . Approximately 2,370,614 shares changed hands during trading, an increase of 141% from the previous session’s volume of 982,008 shares.The stock last traded at $7.56 and had previously closed at $7.59.

Analyst Ratings Changes

LFST has been the topic of several analyst reports. The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective on the stock in a research note on Monday, December 16th. Barclays raised their target price on shares of LifeStance Health Group from $6.00 to $7.00 and gave the company an “underweight” rating in a research report on Monday, November 11th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, LifeStance Health Group currently has an average rating of “Hold” and an average target price of $8.70.

LifeStance Health Group Stock Performance

The company has a market cap of $2.86 billion, a PE ratio of -28.67 and a beta of 1.28. The stock has a 50 day simple moving average of $7.77 and a two-hundred day simple moving average of $7.19. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32.

Insider Buying and Selling

In other news, Director Robert Bessler sold 75,000 shares of the business’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $7.54, for a total transaction of $565,500.00. Following the completion of the sale, the director now owns 1,424,447 shares in the company, valued at approximately $10,740,330.38. The trade was a 5.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 6.60% of the company’s stock.

Hedge Funds Weigh In On LifeStance Health Group

A number of institutional investors have recently added to or reduced their stakes in the company. Blue Trust Inc. grew its position in shares of LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after acquiring an additional 2,122 shares in the last quarter. Townsquare Capital LLC bought a new position in LifeStance Health Group in the 3rd quarter worth approximately $73,000. R Squared Ltd acquired a new stake in LifeStance Health Group in the fourth quarter worth about $80,000. Ameriprise Financial Inc. bought a new position in shares of LifeStance Health Group in the fourth quarter valued at approximately $87,000. Finally, Cibc World Markets Corp acquired a new position in shares of LifeStance Health Group during the 4th quarter valued at $96,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.